Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Airway Topicalization Methods with Dexmedetomidine for Awake Fiberoptic Intubation
NCT06720220Phase 3Completed
- Sponsor
- Zagazig University
- Start
- Jun 2023
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine (4 arms), sponsored by Zagazig University. Primary endpoints: Fiberoptic Intubation Comfort Score, Patient Behavior Score and 1 more. Started Jun 2023; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
Beyond the preview
Go deeper on NCT06720220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06720220.